Ternant, David <br/><br/>
Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.  [electronic resource] 

 -  British journal of clinical pharmacology  Oct 2009 
 - 561-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.2009.03494.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin<br/>Humans<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Middle Aged<br/>Models, Theoretical<br/>Prednisone--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Receptors, IgG<br/>Rituximab<br/>Vincristine--administration & dosage<br/>Young Adult